Nipple sparing subcutaneous mastectomy: sixty-six months follow-up.
Validation of oncological and reconstructive efficacy of nipple sparing subcutaneous mastectomy. We enrolled 50 patients on behalf of Humanitas Centro Catanese di Oncologia fulfilling appropriate reconstructive and oncological criteria to undergo nipple sparing subcutaneous mastectomy. We preferably selected women with medium size-small breast affected by early stage breast cancer peripherally located with intra-operative negative frozen section of the major ducts. fourty-six patients were alive after a mean follow-up of 5.5 years. We observed a single case of local recurrence in the nipple successfully treated with local excision. Five patients presented metastatic disease. One is currently alive, 4 died because of progressive disease. Our study supports other findings regarding safety and efficacy of nipple sparing subcutaneous mastectomy for selected patients.